BILL ANALYSIS

HR67

BULLISH

Modernizing Retrospective Regulatory Review

HR67 (Modernizing Retrospective Regulatory Review) has been assessed with a bullish outlook for investors. This legislation directly affects IBM ($IBM), Microsoft ($MSFT) and Oracle ($ORCL). The primary sectors impacted are Technology. View the full bill text on Congress.gov.

bullish

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR67 mandates all federal agencies adopt AI/algorithmic tools for regulatory review — a new structural procurement category.

The bill is pure authorization with no new appropriations; agencies must reallocate existing IT budgets, limiting near-term scale.

Oracle, Microsoft, and IBM are best positioned due to existing FedRAMP authorization, federal contracts, and general-purpose cloud platforms.

Bill is early-stage: passed House committee on partisan vote, awaiting floor action; Senate companion also in early stages.

Market weakness across affected tickers suggests the structural tailwind is not yet priced in.

How HR67 Affects the Market

The structural driver from HR67 is positive but distant. All three tickers have declined 1-6% in the past week amid broader market weakness. $ORCL ($162.32) and $MSFT ($405.61) show relative strength on a 30-day basis (+10.34% and +9.57% respectively) compared to $IBM (-5.64%), which is trading near its 52-week low. The bill's impact will materialize as it advances through the legislative process — look for floor votes, Senate committee hearings, and eventual OIRA guidance as catalysts. Near-term, these stocks move on earnings and macro, not on a procedural authorization bill. The pure-play AI government contractors like Palantir ($PLTR) may see more immediate sentiment lifts on legislative progress.

Bill Details

Metric	Value
Bill Number	HR67
Market Sentiment	bullish
Event Date	May 21, 2025
Affected Sectors	Technology
Affected Stocks	IBM ($IBM), Microsoft ($MSFT), Oracle ($ORCL)
Source	View on Congress.gov →

Summary

HR67 mandates federal agencies adopt AI-driven regulatory review tools, creating a new procurement category that benefits established FedRAMP-authorized cloud providers. The bill is pure authorization with no direct appropriations, but structural adoption requirements generate recurring revenue for $ORCL, $IBM, and $MSFT. Partner AI providers (e.g., Palantir, C3.ai) are secondary beneficiaries with lower confidence.

Full AI Market Analysis

On January 3, 2025, Rep. Biggs (R-AZ) introduced HR67, the Modernizing Retrospective Regulatory Review Act. The bill was reported out of the House Oversight and Government Reform Committee on May 21, 2025, on a partisan 24-18 vote, and now awaits floor action. A companion bill, S644, has been introduced in the Senate. The bill mandates that OIRA issue guidance within 18 months on how federal agencies can 'identify, procure, and use technology (including algorithmic tools and artificial intelligence)' for retrospective regulatory review. It also requires OIRA to report within 180 days on the availability of regulations in machine-readable format. The money trail is indirect but structural. HR67 is pure authorization — it does not appropriate new funds. Instead, it mandates that all federal agencies adopt specific technology tools, forcing them to reallocate existing IT budgets to comply. The Congressional Budget Office would score this as having no direct spending, but the practical effect is a mandated market shift. Federal IT spending was approximately $100B in FY2025; even a small percentage reallocation to AI regulatory tools represents hundreds of millions in new revenue for incumbent vendors. The mechanism is a procurement mandate, not a grant program — the money flows through standard GSA schedules and FedRAMP-authorized cloud contracts. Structural winners are established federal IT contractors with FedRAMP-authorized AI platforms. Oracle ($ORCL) brings Oracle Government Cloud and OCI AI services. IBM ($IBM) leverages Red Hat OpenShift and watsonx, plus its federal consulting practice. Microsoft ($MSFT) has Azure Government with OpenAI integration already deployed across civilian and defense agencies. These three have the compliance maturity and existing contracts to capture the majority of new spending. Secondary beneficiaries include Palantir ($PLTR) and C3.ai ($AI), which have FedRAMP-authorized platforms but face higher barriers as specialized providers rather than general-purpose cloud platforms. Real market data shows significant recent weakness across all three stocks. $ORCL closed at $162.32 on April 30, 2026, down 6.33% in the 7-day period and well off its 52-week high of $345.72. $IBM closed at $228.72, down 1.41% in the 7-day and down 5.64% over 30 days — trading near its 52-week low of $220.72. $MSFT closed at $405.61, down 4.48% in the 7-day period. These broad declines suggest sector rotation or macro concerns rather than company-specific issues, which means the structural tailwind from HR67 — still in early legislative stages — is not yet priced in. The 30-day changes show $ORCL up 10.34% and $MSFT up 9.57% despite the recent pullback, indicating these stocks have relative strength compared to $IBM. Legislatively, the bill faces an uncertain timeline. It has cleared House committee but awaits floor scheduling — no date is set. The partisan vote (24-18) suggests unified Democratic opposition in the House. The companion bill S644 is in Senate committee with no action. Even if enacted, OIRA has 18 months to issue procurement guidance after passage, meaning actual procurement spending would likely begin in late 2028 or 2029. This is a medium-term structural driver, not an immediate catalyst.